胎盘α微球蛋白-1与胎儿纤维连接蛋白对有症状孕妇早产预测的比较
前瞻性观察研究纳入796名24-35周有早产症状孕妇,711名同时具备胎盘α微球蛋白-1和胎儿纤维连接蛋白结果。胎盘α微球蛋白-1在排除7天内自发性早产方面不劣于胎儿纤维连接蛋白,在预测7天内自发性早产方面优效性更佳。
要点
- 胎盘α微球蛋白-1检测无需窥器,胎儿纤维连接蛋白需窥器采样。
- 7天内自发性早产率1.3%,14天内2.9%。
- 单胎中胎盘α微球蛋白-1阳性预测值为23.1%,胎儿纤维连接蛋白为4.3%。
核心结论
- 胎盘α微球蛋白-1在排除有症状孕妇自发性早产方面与胎儿纤维连接蛋白相同,但在预测方面显示统计学优效性。
研究设计与样本
- 前瞻性观察研究,纳入24至35周有早产症状、胎膜完整且宫颈扩张小于3厘米的孕妇,来自15个美国学术和社区中心。
主要发现
- 在711名分析对象中,7天内早产率为2.4%(17/711),14天内为4.2%(30/711);自发性早产率分别为1.3%(9/703)和2.9%(20/701)。
- 胎儿纤维连接蛋白检出率为15.5%(110/711),胎盘α微球蛋白-1检出率为2.4%(17/711)。
- 单胎妊娠中,7天内自发性早产阳性预测值:胎盘α微球蛋白-1为23.1%(3/13),胎儿纤维连接蛋白为4.3%(4/94),优效性P<.025。
- 阴性预测值:胎盘α微球蛋白-1为99.5%(619/622),胎儿纤维连接蛋白为99.6%(539/541),非劣效性P<.001。
关键数值与推荐
- 胎儿纤维连接蛋白检测以50 ng/mL为 cutoff,通过窥器采集样本送认证实验室检测。
- 胎盘α微球蛋白-1为快速床旁检测,无需窥器。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the rapid bedside test for placental α microglobulin-1 with the instrumented fetal fibronectin test for prediction of imminent spontaneous preterm delivery among women with symptoms of preterm labor. METHODS: We conducted a prospective observational study on pregnant women with signs or symptoms suggestive of preterm labor between 24 and 35 weeks of gestation with intact membranes and cervical dilatation less than 3 cm. Participants were prospectively enrolled at 15 U.S. academic and community centers. Placental α microglobulin-1 samples did not require a speculum examination. Health care providers were blinded to placental α microglobulin-1 results. Fetal fibronectin samples were collected through speculum examination per manufacturer requirements and sent to a certified laboratory for testing using a cutoff of 50 ng/mL. The coprimary endpoints were positive predictive value (PPV) superiority and negative predictive value (NPV) noninferiority of placental α microglobulin-1 compared with fetal fibronectin for the prediction of spontaneous preterm birth within 7 days and within 14 days. RESULTS: Of 796 women included in the study cohort, 711 (89.3%) had both placental α microglobulin-1 and fetal fibronectin results and valid delivery outcomes available for analysis. The overall rate of preterm birth was 2.4% (17/711) within 7 days of testing and 4.2% (30/711) within 14 days of testing with respective rates of spontaneous preterm birth of 1.3% (9/703) and 2.9% (20/701). Fetal fibronectin was detected in 15.5% (110/711), and placental α microglobulin-1 was detected in 2.4% (17/711). The PPVs for spontaneous preterm delivery within 7 days or less among singleton gestations (n=13) for placental α microglobulin-1 and fetal fibronectin were 23.1% (3/13) and 4.3% (4/94), respectively (P<.025 for superiority). The NPVs were 99.5% (619/622) and 99.6% (539/541) for placental α microglobulin-1 and fetal fibronectin, respectively (P<.001 for noninferiority). CONCLUSION: Although placental α microglobulin-1 performed the same as fetal fibronectin in ruling out spontaneous preterm delivery among symptomatic women, it demonstrated statistical superiority in predicting it.
引用
- Wing DA, Haeri S, Silber AC, et al. Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women. Obstet Gynecol. 2017. PMID: 29112664. doi:10.1097/AOG.0000000000002367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。